Cargando…

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)

Detalles Bibliográficos
Autores principales: Eron, J, Livrozet, JM, Morlat, P, Lazzarin, A, Katlama, C, Hawkins, T, Fujiwara, T, Cuffe, R, Vavro, C, Santiago, J, Ait-Khaled, M, Min, S, Yeo, JM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112867/
http://dx.doi.org/10.1186/1758-2652-13-S4-O51
_version_ 1782205835534925824
author Eron, J
Livrozet, JM
Morlat, P
Lazzarin, A
Katlama, C
Hawkins, T
Fujiwara, T
Cuffe, R
Vavro, C
Santiago, J
Ait-Khaled, M
Min, S
Yeo, JM
author_facet Eron, J
Livrozet, JM
Morlat, P
Lazzarin, A
Katlama, C
Hawkins, T
Fujiwara, T
Cuffe, R
Vavro, C
Santiago, J
Ait-Khaled, M
Min, S
Yeo, JM
author_sort Eron, J
collection PubMed
description
format Online
Article
Text
id pubmed-3112867
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31128672011-06-13 Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) Eron, J Livrozet, JM Morlat, P Lazzarin, A Katlama, C Hawkins, T Fujiwara, T Cuffe, R Vavro, C Santiago, J Ait-Khaled, M Min, S Yeo, JM J Int AIDS Soc Oral Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3112867/ http://dx.doi.org/10.1186/1758-2652-13-S4-O51 Text en Copyright ©2010 Min et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Eron, J
Livrozet, JM
Morlat, P
Lazzarin, A
Katlama, C
Hawkins, T
Fujiwara, T
Cuffe, R
Vavro, C
Santiago, J
Ait-Khaled, M
Min, S
Yeo, JM
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title_full Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title_fullStr Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title_full_unstemmed Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title_short Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961)
title_sort activity of the integrase inhibitor s/gsk1349572 in subjects with hiv exhibiting raltegravir resistance: week 24 results of the viking study (ing112961)
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112867/
http://dx.doi.org/10.1186/1758-2652-13-S4-O51
work_keys_str_mv AT eronj activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT livrozetjm activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT morlatp activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT lazzarina activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT katlamac activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT hawkinst activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT fujiwarat activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT cuffer activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT vavroc activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT santiagoj activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT aitkhaledm activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT mins activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961
AT yeojm activityoftheintegraseinhibitorsgsk1349572insubjectswithhivexhibitingraltegravirresistanceweek24resultsofthevikingstudying112961